Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm
Managing Side Effects Based on Dosing Time Gastrointestinal side effects particularly nausea, vomiting, diarrhoea, and constipationare the most commonly reported adverse effects of GLP-1 medications, especially during the initial weeks of treatment or following dose escalation
Following this pattern, patients were on average projected to return to pre-treatment weight by 1.7 years after ceasing medication
The relatively low discontinuation rate despite side effects affecting 39-44% of users underscores an important point: most adverse events are tolerable and manageable, not severe enough to warrant stopping therapy
Note when using this product around the eye area: Use fingertips to apply a thin layer (1-2 drops) underneath the eyes and on the outside areas of the eye
